Pacira pain drug succeeds in late-stage trial

[Reuters] – Pacira Pharmaceuticals Inc said a late-stage trial testing its drug Exparel for a wider use showed the treatment significantly reduced pain compared to placebo in knee surgery patients. Exparel is already approved for use in managing post-sur more

View todays social media effects on PCRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Pacira is hiring next, click here to view